Evidence map›Paper›PMID 42045906›Full record

ArticleJournal of nanobiotechnology2026

Ionic-bridge engineered α-lactalbumin nanoparticles integrated into electrospun nanofibers for controlled growth factor delivery and burn wound repair.

Liangwei Si, Peixin Liu, Yasir Faraz Abbasi, Yang Chen, Xueying Xu, Jiahui Li, Xiaoxuan Zhu, Yuxin Li, Vito Foderà, Dongmei Cun and 2 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Liangwei Si *Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Peixin Liu *Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Yasir Faraz AbbasiWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Yang ChenWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Xueying XuWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Jiahui LiWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Xiaoxuan ZhuWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Yuxin LiWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China.
Vito FoderàDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.
Dongmei CunWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China. cundongmei@163.com.
Xiong GuoWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China. guoxiong186316@gmail.com.
Mingshi YangWuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, 110016, China. mingshi.yang@sund.ku.dk.

Funding

Department of Science and Technology of Liaoning Province 2025JH2/101330180Department of Science and Technology of Liaoning Province XLYC2002061National Natural Science Foundation of China 82173768Novo Nordisk NNF20OC0065260, NNF22OC0080141Overseas Expertise Introduction Project for Discipline Innovation D20029Villum Fonden 19175
6 · The paper itself

Abstract

Protein-based nanoparticles hold great promise for bioactive molecule delivery, but conventional fabrication routes are often complex and rely on surfactants or organic solvents. Here, we reported a crosslinker-free strategy to engineer α-lactalbumin (ALA) nanoparticles via Ca²⁺ mediated ionic bridging and electrospraying, enabling efficient encapsulation of acidic fibroblast growth factor (aFGF). These aFGF@ALA nanoparticles were subsequently integrated into electrospun poly(vinyl alcohol) (PVA) nanofiber matrices to construct hybrid dressings (aFGF@ALA NPs/PVA ENMs). The resulting nanostructures combine the structural support of nanofibers with the controlled release capacity of protein nanoparticles, yielding a synergistic platform for therapeutic delivery. In vitro, the hybrid dressings promoted fibroblasts and keratinocytes proliferation and migration with excellent cytocompatibility. In vivo, they accelerated burn wound repair by enhancing re-epithelialization, collagen I/III remodeling, and angiogenesis. This work introduces a facile and generalizable strategy for designing functional protein-based nanoparticles and demonstrates their integration with nanofiber scaffolds as a versatile platform for growth factor delivery and tissue regeneration.

Indexed as

BurnsLactalbuminNanofibersNanoparticlesWound HealingAnimalsCell MovementCell ProliferationDelayed-Action PreparationsFibroblastsHumansKeratinocytesMicePolyvinyl AlcoholDelayed-Action PreparationsLactalbuminPolyvinyl AlcoholAcid fibroblast growth factorAnanoparticleNanofiber dressingWound healingα-Lactalbumin

Identifiers

PMID42045906
PMCPMC13273961

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.